Lyell Immunopharma (NasdaqGS:LYEL) Update / Briefing November 10, 2025 08:30 AM ET Speaker0Welcome to today's call. Lyle acquires exclusive global rights to a next generation CAR T cell product candidate in clinical development for metastatic colorectal cancer. For those of you who are joining us via Zoom, if you would like to ask a question, please raise your hand by clicking the raise hand at the bottom of your Zoom window. You can raise your hand at any point during the call to enter the queue, and you w ...